Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Gavan

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Journal of Clinical Microbiology|June 1, 1982
Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluationA L Barry, T L Gavan, P B Smith, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolatesP C Fuchs, R N Jones, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersA L Barry, R N Jones, L W Ayers, et al.
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Journal of Clinical Microbiology|December 1, 1978
Multi-laboratory evaluation of an automated microbial detection/identification systemP B Smith, T L Gavan, H D Isenberg, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility testsR N Jones, A L Barry, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteriaP C Fuchs, A L Barry, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteriaP C Fuchs, R N Jones, A L Barry, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Journal of Clinical Microbiology|June 1, 1982
Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluationA L Barry, T L Gavan, P B Smith, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolatesP C Fuchs, R N Jones, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersA L Barry, R N Jones, L W Ayers, et al.
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Journal of Clinical Microbiology|December 1, 1978
Multi-laboratory evaluation of an automated microbial detection/identification systemP B Smith, T L Gavan, H D Isenberg, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility testsR N Jones, A L Barry, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteriaP C Fuchs, A L Barry, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteriaP C Fuchs, R N Jones, A L Barry, et al.
Pageof 10